Cagent Vascular, Inc., the exclusive developer of serration technology for vessel dilation in endovascular interventions, today announced the start of the POINT FORCE Registry, a post-market clinical ...
Cagent Vascular, Inc., a developer of serration technology for vessel dilation in endovascular interventions, announced the sta ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback